HERRON NICAWAY LOZENGES, nicotine 2 mg (as nicotine polacrilex) lozenge blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
29-11-2017

Toimeaine:

nicotine polacrilex, Quantity: 13.33 mg (Equivalent: nicotine, Qty 2 mg)

Saadav alates:

Orion Laboratories Pty Ltd T/A Perrigo Australia

INN (Rahvusvaheline Nimetus):

Nicotine polacrilex

Ravimvorm:

Tablet, uncoated

Koostis:

Excipient Ingredients: mannitol; xanthan gum; potassium bicarbonate; magnesium stearate; sodium carbonate; sodium alginate; aspartame; Flavour

Manustamisviis:

Buccal

Ühikuid pakis:

132, 108, 72, 156, 168, 96, 120, 144, 36

Retsepti tüüp:

Not Scheduled after consideration by Committee

Näidustused:

Relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. Nicotine Lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. If possible, when stopping smoking, should be used in conjunction with behavioural support program.

Toote kokkuvõte:

Visual Identification: Cream/white embossed biconvex round tablet with an odour of peppermint. Embossed with 'L344' on one face.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2010-08-24